Concepedia

James B. Huftalen

JB

Statistics

Publications

7

Citations

228

H-Index

7

Active since

1958

Affiliations

Bristol-Myers Squibb (Germany)(Current)

James B. Huftalen is an author at Bristol-Myers Squibb (Germany) specializing in medicine, cancer pharmacology, and pharmacology.

Publications per year

1958–1985

7

Publications

7

PHARMACOLOGICAL STUDIES WITH KANAMYCIN

D.E. Tisch, James B. Huftalen, H.L. Dickison · Annals of the New York Academy of Sciences · 1958 · 58 citations

, , +1

Antitumor activity and toxicity of cisplatin analogs.

William C. Rose, John E. Schurig, James B. Huftalen et al. · PubMed · 1982 · 58 citations

, , +14

Structural modifications of anguidin and antitumor activities of its analogs

Toshihiko Kaneko, H Schmitz, J. M. Essery et al. · Journal of Medicinal Chemistry · 1982 · 29 citations

, , +6

Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.

William C. Rose, John E. Schurig, James B. Huftalen et al. · PubMed · 1983 · 27 citations

, , +12

Antitumor activity of kijanimicin.

William T. Bradner, C. A. Claridge, James B. Huftalen · The Journal of Antibiotics · 1983 · 26 citations · Full text

, , +9

1–5 of 7